Soligenix
SNGX
#10223
Rank
โ‚ฌ13.94 M
Marketcap
1,38ย โ‚ฌ
Share price
-1.23%
Change (1 day)
-54.26%
Change (1 year)

Soligenix (SNGX) - Total debt

Total debt on the balance sheet as of September 2025 : โ‚ฌ0.33 Million

According to Soligenix's latest financial reports the company's total debt is โ‚ฌ0.33 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Soligenix - Total debt on balance sheet (from 1998 to 2025)

Total debt by year

Year Total debt Change
2024-12-31โ‚ฌ1.42 M-54.87%
2023-12-31โ‚ฌ3.16 M-66.89%
2022-12-31โ‚ฌ9.54 M8.52%
2021-12-31โ‚ฌ8.79 M2.99%
2020-12-31โ‚ฌ8.54 M7421.09%
2019-12-31โ‚ฌ0.11 M
2018-12-31N/A
2016-12-31N/A-100%
2015-12-31โ‚ฌ0.26 M-91.41%
2014-12-31โ‚ฌ3.11 M-48.04%
2013-12-31โ‚ฌ5.99 M
2004-12-31โ‚ฌ0.08 M-70.03%
2003-12-31โ‚ฌ0.28 M-59.16%
2002-12-31โ‚ฌ0.69 M184.4%
2001-12-31โ‚ฌ0.24 M-28.38%
2000-12-31โ‚ฌ0.34 M-12.05%
1999-12-31โ‚ฌ0.38 M15.64%
1998-12-31โ‚ฌ0.33 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Cleveland BioLabs
CBLI
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚ฌ0.56 B 172,109.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ21.92 B 6,630,476.49%๐Ÿ‡ซ๐Ÿ‡ท France
Pfizer
PFE
โ‚ฌ52.26 B 15,802,358.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ39.33 B 11,893,037.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
โ‚ฌ15.95 M 4,724.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ14.66 B 4,433,823.55%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel